Shantou Institute of Ultrasonic Instrument
301602
Hubei Sinophorus Electronic Materials
688545
Pansoft
300996
Jiayu Holding
300117
Wuxi Taclink Optoelectronics Technology
688205
CN Stock MarketDetailed Quotes
688358 Chison Medical Technologies
- 24.59
- +0.33+1.36%
Market Closed Jan 22 15:00 CST
2.76BMarket Cap26.64P/E (TTM)
24.66High24.17Low7.42KlotVolume24.17Open24.26Pre Close18.18MTurnover0.66%Turnover Ratio18.83P/E (Static)112.12MShares37.5952wk High2.00P/B2.76BFloat Cap18.8252wk Low29.11Limit Up112.12MShs Float68.99Historical High19.41Limit Down2.02%Amplitude18.82Historical Low0.80Dividend TTM24.50Avg Price2.96KlotAsk3.25%Div YieldTTM100Lot Size4.32KlotBid
Chison Medical Technologies Key Stats
All
YOY
| (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q3)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q9)Sep 30, 2022 | (Q6)Jun 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | ||||||||||
| Goods sale service render cash | 9.60%341.44M | 11.51%240.23M | 18.76%125.36M | -4.52%426.54M | -6.54%311.54M | 2.11%215.43M | 7.75%105.56M | 24.00%446.75M | 21.53%333.35M | 13.79%210.97M |
| Refunds of taxes and levies | 15.05%25.01M | -13.24%13.57M | -44.80%7.44M | -19.46%30.18M | -31.57%21.74M | -25.99%15.64M | 33.27%13.48M | -1.18%37.47M | 11.57%31.76M | 24.55%21.13M |
| Cash received relating to other operating activities | -39.76%12.23M | -37.55%5.49M | -57.64%2.38M | 101.37%24.78M | 453.42%20.3M | 387.79%8.79M | 313.17%5.62M | 25.33%12.31M | -35.16%3.67M | -7.66%1.8M |
| Cash inflows from operating activities | 7.10%378.67M | 8.10%259.29M | 8.44%135.18M | -3.03%481.5M | -4.12%353.57M | 2.54%239.85M | 13.90%124.66M | 21.69%496.53M | 19.57%368.79M | 14.48%233.9M |
| Goods services cash paid | -7.31%143.63M | -0.03%99.21M | -4.59%50.91M | -19.96%189.34M | -13.81%154.95M | -19.15%99.24M | -8.15%53.36M | 23.51%236.55M | 6.25%179.78M | 10.38%122.74M |
| Staff behalf paid | 1.77%97.55M | -9.67%67.02M | -3.59%38.82M | 7.20%129.52M | 14.53%95.85M | 15.69%74.2M | 13.61%40.27M | 12.73%120.82M | 7.57%83.69M | 20.66%64.14M |
| All taxes paid | 23.68%24.89M | 61.21%16.88M | -30.46%7.38M | -1.22%30.66M | -42.21%20.12M | -36.77%10.47M | -10.47%10.61M | 31.46%31.04M | 70.38%34.82M | -11.31%16.56M |
| Cash paid relating to other operating activities | 19.45%41.98M | 7.40%21.91M | -31.49%11.73M | 3.82%46.07M | -15.77%35.15M | 12.68%20.4M | 23.25%17.13M | -2.95%44.38M | 11.46%41.73M | 16.05%18.1M |
| Cash outflows from operating activities | 0.65%308.05M | 0.35%205.03M | -10.32%108.84M | -8.59%395.6M | -9.98%306.07M | -7.78%204.31M | 1.74%121.36M | 17.59%432.78M | 11.53%340.02M | 11.54%221.55M |
| Net cash flows from operating activities | 48.67%70.62M | 52.66%54.26M | 698.72%26.34M | 34.78%85.91M | 65.12%47.5M | 187.71%35.54M | 133.51%3.3M | 59.51%63.74M | 709.44%28.77M | 117.24%12.35M |
| Investing cash flow | ||||||||||
| Cash received from disposal of investments | 48.44%2.46B | 40.36%1.69B | 31.41%892.27M | 12.33%2.55B | 2.80%1.66B | 21.72%1.21B | -0.15%678.99M | -15.41%2.27B | -27.05%1.61B | -31.01%990M |
| Cash received from returns on investments | -45.03%5.65M | -50.61%3.72M | -53.27%2.09M | -13.21%11.63M | -8.37%10.29M | 14.21%7.53M | -12.56%4.48M | -21.63%13.4M | -17.74%11.23M | -22.73%6.59M |
| Net cash received from disposal of fix assets、 intangible assets 、other long-term asset | --3.49M | --3.33M | ---- | 4,200.24%3.71M | ---- | ---- | ---- | -99.59%86.38K | ---- | ---- |
| Cash received relating to other investing activities | 178.05%18.67M | 128.01%15.31M | --10.08M | --13.51M | --6.71M | --6.71M | ---- | ---- | ---- | ---- |
| Cash inflows from investing activities | 48.60%2.48B | 40.56%1.71B | 32.33%904.44M | 12.93%2.58B | 3.13%1.67B | 22.34%1.22B | -0.24%683.47M | -16.10%2.29B | -27.00%1.62B | -30.96%996.59M |
| Cash paid to acquire fixed assets intangible assets and other long-term assets | -64.12%8.02M | -44.12%6.13M | -49.90%4.45M | -34.86%34.01M | -43.44%22.34M | -44.61%10.98M | -49.88%8.88M | 33.24%52.21M | 31.72%39.51M | -2.03%19.82M |
| Cash paid to acquire investments | 37.38%1.98B | 22.92%1.32B | 39.37%890.55M | 22.71%2.79B | 8.27%1.44B | 17.51%1.08B | 77.50%638.99M | -9.88%2.27B | -19.98%1.33B | 22.47%915M |
| Cash paid relating to other investing activities | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --6.71M | ---- | ---- |
| Cash outflows from investing activities | 35.83%1.99B | 22.25%1.33B | 38.14%895M | 21.07%2.82B | 6.78%1.46B | 16.19%1.09B | 71.52%647.88M | -8.96%2.33B | -19.06%1.37B | 21.83%934.82M |
| Net cash flows from investing activities | 137.63%498.2M | 190.02%385.91M | -73.48%9.44M | -430.83%-241.18M | -16.71%209.65M | 115.41%133.07M | -88.42%35.6M | -127.69%-45.43M | -52.38%251.72M | -90.86%61.77M |
| Financing cash flow | ||||||||||
| Cash received from capital contributions | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --2.02M | --2.02M | ---- |
| Cash inflows from financing activities | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --2.02M | --2.02M | ---- |
| Dividend interest payment | -59.17%32.04M | ---- | ---- | 96.22%78.49M | 96.22%78.49M | ---- | ---- | -37.50%40M | -37.50%40M | ---- |
| Cash payments relating to other financing activities | -44.20%3.04M | 1,650.68%2.22M | --1.19M | 1,094.11%11.05M | 1,071.54%5.44M | -70.02%126.79K | ---- | 50.99%925.05K | 55.68%464.73K | 134.73%422.99K |
| Cash outflows from financing activities | -58.20%35.08M | 1,650.68%2.22M | --1.19M | 118.77%89.53M | 107.42%83.93M | -70.02%126.79K | ---- | -36.66%40.93M | -37.07%40.46M | 134.73%422.99K |
| Net cash flows from financing activities | 58.20%-35.08M | -1,650.68%-2.22M | ---1.19M | -130.13%-89.53M | -118.31%-83.93M | 70.02%-126.79K | ---- | 39.79%-38.91M | 40.21%-38.45M | -134.73%-422.99K |
| Net cash flow | ||||||||||
| Exchange rate change effecting cash and cash equivalents | -162.53%-7.26M | -74.08%3.52M | 120.03%1.16M | -56.75%9.34M | -58.26%11.6M | 10.78%13.59M | -378.66%-5.79M | 822.39%21.59M | 1,613.06%27.8M | 590.55%12.27M |
| Net increase in cash and cash equivalents | 184.85%526.48M | 142.48%441.48M | 8.01%35.75M | -23,874.86%-235.47M | -31.51%184.83M | 111.78%182.07M | -88.83%33.1M | -99.27%990.4K | -42.10%269.84M | -87.34%85.97M |
| Add:Begin period cash and cash equivalents | -53.58%204.02M | -53.58%204.02M | -53.97%204.02M | 0.23%439.49M | 0.23%439.49M | 0.23%439.49M | 1.09%443.27M | 45.17%438.49M | 45.17%438.49M | 45.17%438.49M |
| End period cash equivalent | 17.01%730.5M | 3.85%645.5M | -49.67%239.77M | -53.58%204.02M | -11.86%624.31M | 18.51%621.55M | -35.17%476.38M | 0.23%439.49M | -7.78%708.34M | -46.55%524.47M |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
| Audit Opinions | -- | -- | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion | -- | -- |
| Auditor | -- | -- | -- | Rong Cheng Certified Public Accountants (Special General Partnership) | -- | -- | -- | Rong Cheng Certified Public Accountants (Special General Partnership) | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
